Since PTBP1 was found to be widely overexpressed in pan-cancer, correlated with worse outcomes, extensively involved in several well-known tumor pathways and regulation of tumor cell cycle, we suggested that PTBP1 might be a novo diagnosis and therapeutic target. The gene discussed is PTBP1; the disease is cancer.